US Stock MarketDetailed Quotes

PEARQ Pear Therapeutics

Watchlist

0.000001
0.0000000.00%

15min DelayClose May 24 16:00 ET

142.74Market Cap0.00P/E (TTM)

Pear Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

(Q1)Mar 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-4.45%-113.9M

39.06%-24.28M

8.14%-23.27M

-29.39%-29.64M

-75.13%-36.71M

-60.61%-109.04M

-104.60%-39.84M

-59.45%-25.33M

-22.91M

-20.96M

Net income from continuing operations

-15.89%-75.49M

-240.65%-26.37M

1.84%-30.72M

119.37%5.46M

2.19%-23.86M

32.86%-65.14M

139.35%18.75M

-60.79%-31.3M

---28.2M

---24.39M

Operating gains losses

-2,060.74%-5.84M

113.52%947K

-74.03%495K

-291.36%-10.01M

1,574.23%2.73M

-83.38%298K

-1,038.87%-7M

6,472.41%1.91M

--5.23M

--163K

Depreciation and amortization

153.20%5.7M

105.77%1.53M

87.88%1.47M

304.62%1.4M

243.77%1.3M

422.51%2.25M

258.17%745K

844.58%784K

--346K

--377K

Other non cash items

-1.35%-44.91M

90.70%-4.36M

1,652.69%2.93M

-17,477.25%-29.02M

-754.00%-14.46M

-357.48%-44.32M

-376.07%-46.86M

9.87%167K

--167K

--2.21M

Change In working capital

-64.19%-9.76M

64.59%-2.59M

-146.14%-1.01M

16.73%-851K

-2,538.07%-5.32M

-990.12%-5.95M

-383.39%-7.32M

-24.09%2.18M

---1.02M

--218K

-Change in receivables

-332.05%-5.15M

121.30%240K

-1,001.83%-1.81M

-2,142.62%-1.25M

-6,250.00%-2.34M

-258.72%-1.19M

-431.60%-1.13M

-117.39%-164K

--61K

--38K

-Change in prepaid assets

89.64%-930K

74.55%-1.96M

144.75%354K

185.57%261K

305.00%410K

-8,337.61%-8.98M

-1,100.47%-7.68M

-603.82%-791K

---305K

---200K

-Change in payables and accrued expense

-145.36%-1.84M

-115.48%-221K

-73.39%1.08M

277.25%927K

-296.39%-3.62M

-28.73%4.05M

-55.18%1.43M

131.81%4.06M

---523K

---914K

-Change in other current liabilities

---1.7M

---448K

---431K

---416K

---405K

--0

-Change in other working capital

-183.43%-146K

-435.48%-208K

78.29%-201K

-47.84%-377K

-50.54%640K

102.98%175K

-75.10%62K

-5,244.44%-926K

---255K

--1.29M

Cash from discontinued investing activities

Operating cash flow

-4.45%-113.9M

39.06%-24.28M

8.14%-23.27M

-29.39%-29.64M

-75.13%-36.71M

-60.61%-109.04M

-104.60%-39.84M

-59.45%-25.33M

---22.91M

---20.96M

Investing cash flow

Cash flow from continuing investing activities

-428.03%-9.46M

780.55%11.93M

2,685.93%22.42M

-105.81%-307K

-20,332.56%-43.5M

-95.11%2.88M

61.26%-1.75M

68.07%-867K

5.29M

215K

Net PPE purchase and sale

-5.86%-3.47M

-18.49%-1.07M

33.41%-580K

-84.48%-1.32M

36.50%-501K

15.95%-3.28M

-67.22%-903K

27.96%-871K

---715K

---789K

Net intangibles purchase and sale

--0

----

---1.35M

----

Net investment purchase and sale

-170.34%-5.99M

766.67%13M

574,900.00%23M

-83.14%1.01M

-4,382.77%-43M

-86.61%8.51M

137.64%1.5M

100.27%4K

--6M

--1M

Net other investing changes

----

-33.33%-1M

----

Cash from discontinued investing activities

Investing cash flow

-428.03%-9.46M

780.55%11.93M

2,685.93%22.42M

-105.81%-307K

-20,332.56%-43.5M

-95.11%2.88M

61.26%-1.75M

68.07%-867K

--5.29M

--215K

Financing cash flow

Cash flow from continuing financing activities

-98.69%2.16M

-99.35%961K

110.00%358K

219.47%761K

-99.63%75K

78.92%164.08M

86.88%147.98M

-1,994.71%-3.58M

-637K

20.32M

Net issuance payments of debt

--0

----

-107.29%-1M

----

Net preferred stock issuance

--0

-82.07%19.92M

-100.00%-1K

--3K

---2K

--19.92M

Proceeds from stock option exercised by employees

150.87%2.16M

1,616.07%961K

167.16%358K

185.02%761K

-81.34%75K

110.02%859K

-47.66%56K

-29.10%134K

--267K

--402K

Net other financing activities

----

9,720.07%144.3M

--148.92M

---3.72M

----

Cash from discontinued financing activities

Financing cash flow

-98.69%2.16M

-99.35%961K

110.00%358K

219.47%761K

-99.63%75K

78.92%164.08M

86.88%147.98M

-1,994.71%-3.58M

---637K

--20.32M

Net cash flow

Beginning cash position

51.68%169.98M

-5.39%60.17M

-35.04%60.66M

-19.52%89.85M

51.68%169.98M

282.11%112.06M

11.81%63.6M

24.02%93.38M

--111.63M

--112.06M

Current changes in cash

-309.26%-121.2M

-110.71%-11.39M

98.35%-492K

-59.87%-29.18M

-18,666.51%-80.13M

-30.00%57.92M

92.78%106.38M

-61.73%-29.78M

---18.25M

---427K

End cash Position

-71.30%48.78M

-5.39%60.17M

-35.04%60.66M

-19.52%89.85M

51.68%169.98M

11.81%63.6M

--93.38M

--111.63M

Free cash flow

-3.25%-117.37M

39.78%-25.35M

8.98%-23.85M

-31.06%-30.96M

-71.08%-37.21M

-58.33%-113.67M

-110.34%-42.1M

-53.27%-26.2M

---23.62M

---21.75M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021	(Q1)Mar 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-4.45%-113.9M	39.06%-24.28M	8.14%-23.27M	-29.39%-29.64M	-75.13%-36.71M	-60.61%-109.04M	-104.60%-39.84M	-59.45%-25.33M	-22.91M	-20.96M
Net income from continuing operations	-15.89%-75.49M	-240.65%-26.37M	1.84%-30.72M	119.37%5.46M	2.19%-23.86M	32.86%-65.14M	139.35%18.75M	-60.79%-31.3M	---28.2M	---24.39M
Operating gains losses	-2,060.74%-5.84M	113.52%947K	-74.03%495K	-291.36%-10.01M	1,574.23%2.73M	-83.38%298K	-1,038.87%-7M	6,472.41%1.91M	--5.23M	--163K
Depreciation and amortization	153.20%5.7M	105.77%1.53M	87.88%1.47M	304.62%1.4M	243.77%1.3M	422.51%2.25M	258.17%745K	844.58%784K	--346K	--377K
Other non cash items	-1.35%-44.91M	90.70%-4.36M	1,652.69%2.93M	-17,477.25%-29.02M	-754.00%-14.46M	-357.48%-44.32M	-376.07%-46.86M	9.87%167K	--167K	--2.21M
Change In working capital	-64.19%-9.76M	64.59%-2.59M	-146.14%-1.01M	16.73%-851K	-2,538.07%-5.32M	-990.12%-5.95M	-383.39%-7.32M	-24.09%2.18M	---1.02M	--218K
-Change in receivables	-332.05%-5.15M	121.30%240K	-1,001.83%-1.81M	-2,142.62%-1.25M	-6,250.00%-2.34M	-258.72%-1.19M	-431.60%-1.13M	-117.39%-164K	--61K	--38K
-Change in prepaid assets	89.64%-930K	74.55%-1.96M	144.75%354K	185.57%261K	305.00%410K	-8,337.61%-8.98M	-1,100.47%-7.68M	-603.82%-791K	---305K	---200K
-Change in payables and accrued expense	-145.36%-1.84M	-115.48%-221K	-73.39%1.08M	277.25%927K	-296.39%-3.62M	-28.73%4.05M	-55.18%1.43M	131.81%4.06M	---523K	---914K
-Change in other current liabilities	---1.7M	---448K	---431K	---416K	---405K	--0	--0	--0	--0	--0
-Change in other working capital	-183.43%-146K	-435.48%-208K	78.29%-201K	-47.84%-377K	-50.54%640K	102.98%175K	-75.10%62K	-5,244.44%-926K	---255K	--1.29M
Cash from discontinued investing activities
Operating cash flow	-4.45%-113.9M	39.06%-24.28M	8.14%-23.27M	-29.39%-29.64M	-75.13%-36.71M	-60.61%-109.04M	-104.60%-39.84M	-59.45%-25.33M	---22.91M	---20.96M
Investing cash flow
Cash flow from continuing investing activities	-428.03%-9.46M	780.55%11.93M	2,685.93%22.42M	-105.81%-307K	-20,332.56%-43.5M	-95.11%2.88M	61.26%-1.75M	68.07%-867K	5.29M	215K
Net PPE purchase and sale	-5.86%-3.47M	-18.49%-1.07M	33.41%-580K	-84.48%-1.32M	36.50%-501K	15.95%-3.28M	-67.22%-903K	27.96%-871K	---715K	---789K
Net intangibles purchase and sale	--0	----	----	----	----	---1.35M	----	----	----	----
Net investment purchase and sale	-170.34%-5.99M	766.67%13M	574,900.00%23M	-83.14%1.01M	-4,382.77%-43M	-86.61%8.51M	137.64%1.5M	100.27%4K	--6M	--1M
Net other investing changes	----	----	----	----	----	-33.33%-1M	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	-428.03%-9.46M	780.55%11.93M	2,685.93%22.42M	-105.81%-307K	-20,332.56%-43.5M	-95.11%2.88M	61.26%-1.75M	68.07%-867K	--5.29M	--215K
Financing cash flow
Cash flow from continuing financing activities	-98.69%2.16M	-99.35%961K	110.00%358K	219.47%761K	-99.63%75K	78.92%164.08M	86.88%147.98M	-1,994.71%-3.58M	-637K	20.32M
Net issuance payments of debt	--0	----	----	----	----	-107.29%-1M	----	----	----	----
Net preferred stock issuance	--0	--0	--0	--0	--0	-82.07%19.92M	-100.00%-1K	--3K	---2K	--19.92M
Proceeds from stock option exercised by employees	150.87%2.16M	1,616.07%961K	167.16%358K	185.02%761K	-81.34%75K	110.02%859K	-47.66%56K	-29.10%134K	--267K	--402K
Net other financing activities	----	----	----	----	----	9,720.07%144.3M	--148.92M	---3.72M	----	----
Cash from discontinued financing activities
Financing cash flow	-98.69%2.16M	-99.35%961K	110.00%358K	219.47%761K	-99.63%75K	78.92%164.08M	86.88%147.98M	-1,994.71%-3.58M	---637K	--20.32M
Net cash flow
Beginning cash position	51.68%169.98M	-5.39%60.17M	-35.04%60.66M	-19.52%89.85M	51.68%169.98M	282.11%112.06M	11.81%63.6M	24.02%93.38M	--111.63M	--112.06M
Current changes in cash	-309.26%-121.2M	-110.71%-11.39M	98.35%-492K	-59.87%-29.18M	-18,666.51%-80.13M	-30.00%57.92M	92.78%106.38M	-61.73%-29.78M	---18.25M	---427K
End cash Position	-71.30%48.78M	-71.30%48.78M	-5.39%60.17M	-35.04%60.66M	-19.52%89.85M	51.68%169.98M	51.68%169.98M	11.81%63.6M	--93.38M	--111.63M
Free cash flow	-3.25%-117.37M	39.78%-25.35M	8.98%-23.85M	-31.06%-30.96M	-71.08%-37.21M	-58.33%-113.67M	-110.34%-42.1M	-53.27%-26.2M	---23.62M	---21.75M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall